Penny stocks to buy for under $1 but are they worth the risk? The post Best Penny Stocks to Buy Under $1? 4 To Watch Now...
No word on the release of fourth quarter earnings. The post Cybin Releases Corporate Update appeared first on Green Market Report.
Mind Medicine Inc (NASDAQ: MNMD / NEO: MMED), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders,...
The article Cybin Doses Last Patient in Part B of Phase 1 DMT Trial was originally published on Microdose. Cybin moves its DMT program forward as...
The first three months of 2023 have been a whirlwind for the psychedelic industry– to say the least. Though it has been a particularly difficult quarter,...
Cybin Inc. (NEO:CYBN / NYSE American:CYBN) a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new...
Cybin Inc. (NEO:CYBN | NYSE American:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics ® today announced significant...
The article Cybin Reports Q3 Financial Results and Business Highlights was originally published on Microdose. Cybin has released its Q3 financial results...
The company received approval in the Netherlands to start dosing humans with one of its compounds. The post Cybin Maintains Steady Runway, Finds Approval...
The company has raised $39 million to optimize existing substances, which they say will make them safer and more effective. The post Gilgamesh Tweaks Known...